The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.
Natera wins FDA approval for companion diagnostic
The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.